The Cooper Companies, Inc. (NASDAQ: COO) Stock Competitors & Peer Comparison
See COO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for COO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
| AVTR | $11.44 | +0.79% | 7.8B | 13.46 | $0.85 | N/A |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
COO vs BDX Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BDX's P/E ratio is 11.62. In terms of profitability, COO's ROE is +0.03%, compared to BDX's ROE of +0.05%. Regarding short-term risk, COO is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
COO vs BDXA Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BDXA's P/E ratio is 45.70. In terms of profitability, COO's ROE is +0.03%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, COO is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
COO vs MDLN Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, MDLN has a market cap of 32.8B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while MDLN trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas MDLN's P/E ratio is 45.06. In terms of profitability, COO's ROE is +0.03%, compared to MDLN's ROE of +0.07%. Regarding short-term risk, COO is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for COO.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
COO vs WST Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas WST's P/E ratio is 41.19. In terms of profitability, COO's ROE is +0.03%, compared to WST's ROE of +0.19%. Regarding short-term risk, COO is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for COO.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
COO vs HOLX Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas HOLX's P/E ratio is 31.54. In terms of profitability, COO's ROE is +0.03%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, COO is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for COO.Check HOLX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
COO vs BDXB Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BDXB's P/E ratio is 7.60. In terms of profitability, COO's ROE is +0.03%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, COO is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
COO vs BAX Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BAX's P/E ratio is 10.77. In terms of profitability, COO's ROE is +0.03%, compared to BAX's ROE of -0.16%. Regarding short-term risk, COO is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for COO.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
COO vs ATR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ATR's P/E ratio is 23.13. In terms of profitability, COO's ROE is +0.03%, compared to ATR's ROE of +0.14%. Regarding short-term risk, COO is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for COO.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
COO vs AVTR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas AVTR's P/E ratio is 13.46. In terms of profitability, COO's ROE is +0.03%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, COO is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for COO.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
COO vs RGEN Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas RGEN's P/E ratio is 73.31. In terms of profitability, COO's ROE is +0.03%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, COO is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for COO.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
COO vs TFX Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas TFX's P/E ratio is 12.32. In terms of profitability, COO's ROE is +0.03%, compared to TFX's ROE of -0.28%. Regarding short-term risk, COO is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for COO.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
COO vs BLCO Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BLCO's P/E ratio is 24.88. In terms of profitability, COO's ROE is +0.03%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, COO is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for COO.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
COO vs STVN Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas STVN's P/E ratio is 31.81. In terms of profitability, COO's ROE is +0.03%, compared to STVN's ROE of +0.10%. Regarding short-term risk, COO is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for COO.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
COO vs MMSI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas MMSI's P/E ratio is 19.01. In terms of profitability, COO's ROE is +0.03%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, COO is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for COO.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
COO vs ICUI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ICUI's P/E ratio is 19.66. In terms of profitability, COO's ROE is +0.03%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, COO is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for COO.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
COO vs HAE Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas HAE's P/E ratio is 15.86. In terms of profitability, COO's ROE is +0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, COO is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for COO.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
COO vs XRAY Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas XRAY's P/E ratio is 9.04. In terms of profitability, COO's ROE is +0.03%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, COO is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for COO.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
COO vs LMAT Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas LMAT's P/E ratio is 37.05. In terms of profitability, COO's ROE is +0.03%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, COO is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for COO.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
COO vs PLSE Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas PLSE's P/E ratio is -27.48. In terms of profitability, COO's ROE is +0.03%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, COO is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for COO.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
COO vs ATRC Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, COO's ROE is +0.03%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, COO is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for COO.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
COO vs BLFS Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas BLFS's P/E ratio is -141.85. In terms of profitability, COO's ROE is +0.03%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, COO is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for COO.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
COO vs AZTA Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas AZTA's P/E ratio is 60.82. In terms of profitability, COO's ROE is +0.03%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, COO is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for COO.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
COO vs KMTS Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas KMTS's P/E ratio is -8.92. In terms of profitability, COO's ROE is +0.03%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, COO is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for COO.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
COO vs STAA Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas STAA's P/E ratio is 41.02. In terms of profitability, COO's ROE is +0.03%, compared to STAA's ROE of -0.06%. Regarding short-term risk, COO is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for COO.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
COO vs QDEL Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas QDEL's P/E ratio is 11.98. In terms of profitability, COO's ROE is +0.03%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, COO is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for COO.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
COO vs ATRI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ATRI's P/E ratio is 64.50. In terms of profitability, COO's ROE is +0.03%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, COO is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for COO.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
COO vs ANGO Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ANGO's P/E ratio is -34.85. In terms of profitability, COO's ROE is +0.03%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, COO is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for COO.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
COO vs NNNN Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas NNNN's P/E ratio is 145.38. In terms of profitability, COO's ROE is +0.03%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, COO is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for COO.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
COO vs OSUR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas OSUR's P/E ratio is -4.78. In terms of profitability, COO's ROE is +0.03%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, COO is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for COO.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
COO vs SMTI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas SMTI's P/E ratio is -426.00. In terms of profitability, COO's ROE is +0.03%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, COO is less volatile compared to SMTI. This indicates lower risk in terms of short-term price fluctuations for COO.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
COO vs UTMD Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas UTMD's P/E ratio is 19.86. In terms of profitability, COO's ROE is +0.03%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, COO is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for COO.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
COO vs INFU Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas INFU's P/E ratio is 23.97. In terms of profitability, COO's ROE is +0.03%, compared to INFU's ROE of +0.14%. Regarding short-term risk, COO is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for COO.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
COO vs KRMD Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas KRMD's P/E ratio is -95.75. In terms of profitability, COO's ROE is +0.03%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, COO is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for COO.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
COO vs PDEX Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas PDEX's P/E ratio is 19.34. In terms of profitability, COO's ROE is +0.03%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, COO is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for COO.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
COO vs MBOT Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas MBOT's P/E ratio is -6.58. In terms of profitability, COO's ROE is +0.03%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, COO is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for COO.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
COO vs AKYA Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas AKYA's P/E ratio is -1.34. In terms of profitability, COO's ROE is +0.03%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, COO is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for COO.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
COO vs STSS Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas STSS's P/E ratio is -0.02. In terms of profitability, COO's ROE is +0.03%, compared to STSS's ROE of -1.66%. Regarding short-term risk, COO is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for COO.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
COO vs DXR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas DXR's P/E ratio is 27.33. In terms of profitability, COO's ROE is +0.03%, compared to DXR's ROE of +0.22%. Regarding short-term risk, COO is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for COO.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
COO vs OMIC Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas OMIC's P/E ratio is -0.58. In terms of profitability, COO's ROE is +0.03%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, COO is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for COO.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
COO vs IGAP Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas IGAP's P/E ratio is -10.52. In terms of profitability, COO's ROE is +0.03%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, COO is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for COO.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
COO vs NEPH Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas NEPH's P/E ratio is 50.86. In terms of profitability, COO's ROE is +0.03%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, COO is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for COO.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
COO vs MLSS Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, MLSS has a market cap of 34.5M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while MLSS trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas MLSS's P/E ratio is -6.50. In terms of profitability, COO's ROE is +0.03%, compared to MLSS's ROE of -1.66%. Regarding short-term risk, COO is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for COO.Check MLSS's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
COO vs POCI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas POCI's P/E ratio is -6.07. In terms of profitability, COO's ROE is +0.03%, compared to POCI's ROE of -0.37%. Regarding short-term risk, COO is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for COO.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
COO vs SDC Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas SDC's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to SDC's ROE of -1.96%. Regarding short-term risk, COO is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for COO.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
COO vs HBIO Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas HBIO's P/E ratio is -16.81. In terms of profitability, COO's ROE is +0.03%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, COO is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for COO.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
COO vs IVC Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas IVC's P/E ratio is -0.79. In terms of profitability, COO's ROE is +0.03%, compared to IVC's ROE of -0.46%. Regarding short-term risk, COO is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for COO.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
COO vs RVP Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas RVP's P/E ratio is -2.06. In terms of profitability, COO's ROE is +0.03%, compared to RVP's ROE of -0.08%. Regarding short-term risk, COO is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for COO.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
COO vs ZJYL Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ZJYL trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ZJYL's P/E ratio is 12.75. In terms of profitability, COO's ROE is +0.03%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for COO.Check ZJYL's competition here
Femasys Inc. (NASDAQ: FEMY)
COO vs FEMY Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas FEMY's P/E ratio is -10.25. In terms of profitability, COO's ROE is +0.03%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, COO is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for COO.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
COO vs RGNT Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas RGNT's P/E ratio is -0.08. In terms of profitability, COO's ROE is +0.03%, compared to RGNT's ROE of N/A. Regarding short-term risk, COO is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for COO.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
COO vs NSTG Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas NSTG's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, COO is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for COO.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
COO vs NXGL Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas NXGL's P/E ratio is -1.13. In terms of profitability, COO's ROE is +0.03%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, COO is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for COO.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
COO vs POAI Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas POAI's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to POAI's ROE of -107.05%. Regarding short-term risk, COO is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for COO.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
COO vs LUCY Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas LUCY's P/E ratio is -0.39. In terms of profitability, COO's ROE is +0.03%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, COO is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for COO.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
COO vs MHUA Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas MHUA's P/E ratio is 0.25. In terms of profitability, COO's ROE is +0.03%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, COO is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for COO.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
COO vs NXGLW Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, COO's ROE is +0.03%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, COO is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for COO.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
COO vs GMVD Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas GMVD's P/E ratio is -0.01. In terms of profitability, COO's ROE is +0.03%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, COO is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for COO.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
COO vs GMVDW Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas GMVDW's P/E ratio is N/A. In terms of profitability, COO's ROE is +0.03%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, COO is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for COO.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
COO vs AVGR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas AVGR's P/E ratio is -0.05. In terms of profitability, COO's ROE is +0.03%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, COO is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for COO.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
COO vs LUCYW Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, COO's ROE is +0.03%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, COO is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for COO.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
COO vs GCTK Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas GCTK's P/E ratio is -0.01. In terms of profitability, COO's ROE is +0.03%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, COO is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for COO.Check GCTK's competition here
Apria, Inc. (NASDAQ: APR)
COO vs APR Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, APR has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas APR's P/E ratio is 22.59. In terms of profitability, COO's ROE is +0.03%, compared to APR's ROE of +9.81%. Regarding short-term risk, COO is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for COO.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
COO vs IIN Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, IIN has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas IIN's P/E ratio is 226.45. In terms of profitability, COO's ROE is +0.03%, compared to IIN's ROE of -0.00%. Regarding short-term risk, COO is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for COO.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
COO vs ALOG Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ALOG's P/E ratio is 40.93. In terms of profitability, COO's ROE is +0.03%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, COO is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for COO.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
COO vs ATRS Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas ATRS's P/E ratio is 14.95. In terms of profitability, COO's ROE is +0.03%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, COO is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for COO.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
COO vs IVTY Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas IVTY's P/E ratio is -3.80. In terms of profitability, COO's ROE is +0.03%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, COO is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for COO.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
COO vs HRC Comparison July 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 13.7B. In comparison, HRC has a market cap of 0. Regarding current trading prices, COO is priced at $70.31 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 15.42, whereas HRC's P/E ratio is 41.92. In terms of profitability, COO's ROE is +0.03%, compared to HRC's ROE of +0.14%. Regarding short-term risk, COO is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for COO.Check HRC's competition here